Failure to Adhere to Protocol Specified Radiation Therapy Guidelines Was Associated With Decreased Survival in RTOG 9704-A Phase III Trial of Adjuvant Chemotherapy and Chemoradiotherapy for Patients With Resected Adenocarcinoma of the Pancreas
Journal Article
·
· International Journal of Radiation Oncology, Biology and Physics
- Radiation Therapy Oncology Group Statistical Center, Philadelphia, PA (United States)
- University of Maryland, Baltimore, MD (United States)
- Brown University, Providence, RI (United States)
- Fox Chase Cancer Center, Philadelphia, PA (United States)
- Wayne State Medical Center, Detroit, MI (United States)
- Northwestern University, Chicago, IL (United States)
- St. Vincent's Cancer Care Center, New York, NY (United States)
- University of Virginia, Charlottesville, VA (United States)
- Duke University, Durham, NC (United States)
Purpose: In Radiation Therapy Oncology Group 9704, as previously published, patients with resected pancreatic adenocarcinoma received continuous infusion 5-FU and concurrent radiotherapy (5FU-RT). 5FU-RT treatment was preceded and followed by randomly assigned chemotherapy, either 5-FU or gemcitabine. This analysis explored whether failure to adhere to specified RT guidelines influenced survival and/or toxicity. Methods and Materials: RT requirements were protocol specified. Adherence was scored as per protocol (PP) or less than per protocol (
- OSTI ID:
- 22056038
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Vol. 82, Issue 2; Other Information: Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
- Country of Publication:
- United States
- Language:
- English
Similar Records
Five Year Results of US Intergroup/RTOG 9704 With Postoperative CA 19-9 {<=}90 U/mL and Comparison to the CONKO-001 Trial
Survival After Chemoradiation in Resected Pancreatic Cancer: The Impact of Adjuvant Gemcitabine
Impact of Gemcitabine Chemotherapy and 3-Dimensional Conformal Radiation Therapy/5-Fluorouracil on Quality of Life of Patients Managed for Pancreatic Cancer
Journal Article
·
Thu Nov 01 00:00:00 EDT 2012
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:22056038
+6 more
Survival After Chemoradiation in Resected Pancreatic Cancer: The Impact of Adjuvant Gemcitabine
Journal Article
·
Sun Jul 01 00:00:00 EDT 2012
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:22056038
+3 more
Impact of Gemcitabine Chemotherapy and 3-Dimensional Conformal Radiation Therapy/5-Fluorouracil on Quality of Life of Patients Managed for Pancreatic Cancer
Journal Article
·
Tue Jan 01 00:00:00 EST 2013
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:22056038
+5 more